SMTL ID : 6qac.1

Human Butyrylcholinesterase in complex with (S)-2-(butylamino)-N-(3-cycloheptylpropyl)-3-(1H-indol-3-yl)propanamide

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.77 Å

Oligo State

monomer

Ligands

1 x NAG- FUC: alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-FUC.1: 2 residues within 4Å: Chain A: R.42, N.85 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:R.42, A:N.85

1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-FUC.2: 3 residues within 4Å: Chain A: S.366, N.369, N.370 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.377

1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.3: 2 residues within 4Å: Chain A: N.269, N.273 No protein-ligand interaction detected (PLIP)

3 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.4: 2 residues within 4Å: Chain A: N.134, N.216 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:N.134 Hydrogen bonds: A:N.216 NAG.5: 2 residues within 4Å: Chain A: N.284, E.287 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.287 NAG.6: 4 residues within 4Å: Chain A: R.493, K.497, E.510, N.513 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:K.497 Hydrogen bonds: A:R.493

1 x HUT: (2~{S})-2-(butylamino)-~{N}-(3-cycloheptylpropyl)-3-(1~{H}-indol-3-yl)propanamide(Non-covalent)

HUT.7: 18 residues within 4Å: Chain A: W.110, G.144, G.145, S.226, W.259, T.312, P.313, L.314, S.315, V.316, N.317, A.356, F.357, Y.360, F.426, W.458, H.466 Ligands: DMS.8 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:W.259, A:V.316, A:A.356, A:F.357, A:F.357, A:Y.360, A:Y.360, A:F.426, A:W.458 Hydrogen bonds: A:P.313 pi-Stacking: A:W.259, A:W.259

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.8: 7 residues within 4Å: Chain A: W.110, G.143, G.144, Y.156, E.225, S.226 Ligands: HUT.7 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:S.226 Salt bridges: A:E.225 pi-Cation interactions: A:W.110

4 x SO4: SULFATE ION(Non-functional Binders)

SO4.9: 4 residues within 4Å: Chain A: Q.344, G.441, N.442, N.443 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:Q.344, A:G.441, A:N.442, A:N.443 SO4.10: 4 residues within 4Å: Chain A: R.270, L.314, S.315, V.316 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:V.316 Water bridges: A:W.259, A:V.316 Salt bridges: A:R.270 SO4.11: 3 residues within 4Å: Chain A: S.515, T.516, T.536 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:S.515, A:T.516, A:T.536, A:T.536 SO4.12: 3 residues within 4Å: Chain A: R.375, K.376, Q.379 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Q.379 Salt bridges: A:R.375, A:K.376

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Meden, A. et al., Tryptophan-derived butyrylcholinesterase inhibitors as promising leads against Alzheimer's disease. Chem.Commun.(Camb.) (2019)

Release Date

2019-03-27

Peptides

Cholinesterase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cholinesterase

Related Entries With Identical Sequence